Biodegradable Polymer Drug-Eluting Stents Reduce the Risk of Stent Thrombosis at 4 Years in Patients Undergoing Percutaneous Coronary Intervention: A Pooled Analysis of Individual Patient Data From the ISAR-TEST 3, ISAR-TEST 4, and LEADERS Randomized Trials

Study Questions:

What are the long-term outcomes in patients treated with biodegradable polymer drug-eluting stents (DES) versus durable polymer sirolimus-eluting stents (SES)?